Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sanofi to buy Vigil Neuroscience in USD 470 million deal

Bigfoot becomes wholly owned subsidiary of Abbott

Ruchika Sharma23 Sept 2023 10:00 AM IST

Abbott Park, Ill.: Abbott has announced it has completed the acquisition of Bigfoot Biomedical, a company developing smart insulin management...

Lupin buys five brands from Menarini

Ruchika Sharma22 Sept 2023 5:10 PM IST

The brands are Piclin (Picosulphate Sodium), Menoctyl (Otilonium Bromide), Sucramal O (Sucralfate + Oxetacaine), Pyridium (Phenazopyridine) and...

HIV drug kickbacks: Gilead Sciences to pay USD 202 million to settle lawsuit

EMA Committee grants positive opinion for Veklury use to treat COVID 19 in people with Hepatic impairment

Ruchika Sharma22 Sept 2023 3:30 PM IST

Foster City: Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...

USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas Pharma

AstraZeneca rare disease unit acquires Pfizer portfolio for USD 1 billion

Ruchika Sharma22 Sept 2023 2:25 PM IST

AstraZeneca's Rare-Disease Unit

Alkem Labs Slapped Rs 2.34 Cr GST Demand in Goa

Alkem Labs brands API business as Alkem Activa

Ruchika Sharma22 Sept 2023 12:40 PM IST

By forging partnerships and collaborations, Alkem Activa aims to become a reliable supplier of high- quality APIs to pharmaceutical companies...

Glenmark Pharma to divest 75 percent stake in Glenmark Life Sciences to Nirma for Rs 5651 crore

Ruchika Sharma22 Sept 2023 11:54 AM IST

"Glenmark Pharma will continue to focus on consistent growth across its key markets whilst having a strong emphasis on return ratios with net cash...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck gets USFDA priority review for Keytruda plus concurrent chemoradiotherapy for cervical cancer

Ruchika Sharma21 Sept 2023 5:33 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...

India to mandate annual audit of pharma suppliers by drugmakers

Ruchika Sharma21 Sept 2023 4:30 PM IST

Drugmakers will also have to inform their licensing authorities, generally the drug regulator of the state where they are based, of all product...

Pfizer Litfulo gets European Commission approval for adolescents, adults with severe alopecia areata

Ruchika Sharma21 Sept 2023 3:30 PM IST

New York: Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for LITFULO (ritlecitinib) to treat...

Merck Welireg get USFDA priority review for certain previously treated patients with Advanced Renal Cell Carcinoma

Ruchika Sharma21 Sept 2023 2:48 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted and...

Biocon unveils Liraglutide for diabetes, obesity in Netherlands

Biocon Biologics gets European Commission nod for critical eye treatment medicine Yesafili

Ruchika Sharma21 Sept 2023 1:30 PM IST

Bengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., has announced that the European Commission (EC) has granted marketing authorization in...

USFDA issues 5 observations to Cipla US arm

Ruchika Sharma21 Sept 2023 12:30 PM IST

Mumbai: Cipla has recently announced that the United States Food and Drug Administration (USFDA) has concluded the inspection with five...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok